Clinical Trials Logo
  1. Home
  2. Neonatal Hyperbilirubinemia
  3. NCT01340339

Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants

Neonatal Hyperbilirubinemia Clinical Trial

Official title:
Efficacy of Reverse Phototherapy With Super Light-emitting Diode(Super-led) in Term and Late Preterm Infants:Randomized and Controlled Clinical Trial

Clinical Trial Summary

The aim of this study is to compare the efficacy of super-LED reverse phototherapy with the fluorescent reverse phototherapy in term and late preterm newborns.

Clinical Trial Description

This is a randomized controlled clinical trial with hospitalized infants in the Professor Fernando Figueira Medicine Institute(IMIP), who require phototherapy as an indication of the medical team. Following the sample calculation, 144 patients will be randomized according to gestational age (350/7-376/7 or 380/7-416/7 weeks) to receive super-LED reverse phototherapy or fluorescent reverse phototherapy with spectral irradiance of 8-12 microwatts/cm2/nm.The bilirubin will be determined by micromethod with bilirubinometer, after blood collection in heparinized capillary until bilirubin reaches level that indicates suspension of therapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01340339
Study type Interventional
Source Professor Fernando Figueira Integral Medicine Institute
Contact Danielle Cintra Bezerra Brandão
Phone +558191427761
Email daniellecbb@yahoo.com.br
Status Unknown status
Phase Phase 4
Start date October 2010
Completion date January 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06186349 - The Effect and Mechanism of Gene Variation on Neonatal Hyperbilirubinemia
Recruiting NCT04369313 - Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers N/A
Not yet recruiting NCT04585828 - Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy N/A
Completed NCT02927093 - Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life N/A
Completed NCT02033096 - Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
Recruiting NCT04218318 - Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn N/A
Active, not recruiting NCT02602301 - The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels Phase 4
Completed NCT00801619 - Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia N/A
Active, not recruiting NCT05343403 - Parental Participation on the Neonatal Ward - the neoPARTNER Study
Completed NCT03880591 - Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo
Completed NCT01599611 - Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study N/A
Recruiting NCT06399146 - Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana N/A
Completed NCT06018012 - MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates
Completed NCT03536078 - Home Phototherapy for Term Newborns With Icterus N/A
Withdrawn NCT00917007 - Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Recruiting NCT00154960 - Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform. N/A
Recruiting NCT02594904 - Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency Phase 4
Completed NCT01746511 - Glycerin Suppositories to Reduce Jaundice in Premature Infants N/A
Completed NCT01470820 - Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a "Saturation Point" N/A
Completed NCT02361788 - Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)